PERCEPTIVE ADVISORS LLC

Position in CTNM — Contineum Therapeutics, Inc.

CIK 1224962 NEW YORK, NY

Position in CTNM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$20,579,152

+$4,181,121 QoQ

Shares Held

1,255,592

0.0% QoQ

Ownership

3.34%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

of 101 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PERCEPTIVE ADVISORS LLC holds $5,486,611,234 across 68 Biotechnology names. CTNM ranks #43 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	2,035,986	$681,627,752
2	SYRE	Spyre Therapeutics, Inc.	4,319,496	$383,484,854
3	CELC	Celcuity Inc.	3,197,200	$334,491,064
4	ASND	Ascendis Pharma A/S	1,163,721	$310,387,665
5	RYTM	Rhythm Pharmaceuticals, Inc.	2,586,295	$287,156,333
6	ROIV	Roivant Sciences Ltd.	8,085,461	$286,144,464
7	RLAY	Relay Therapeutics, Inc.	14,106,187	$263,926,758
8	TVTX	Travere Therapeutics, Inc.	3,752,574	$213,183,728

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,579,152	1,255,592	0.0%	Shares	Sole	2026-08-14
2026-03-31	$16,398,031	1,255,592	-14.3%	Shares	Sole	2026-05-29
2025-12-31	$16,740,286	1,464,592	+105.0%	Shares	Sole	2026-02-17
2025-09-30	$8,396,456	714,592	+2.2%	Shares	Sole	2025-11-14
2025-06-30	$2,776,959	699,486	-51.5%	Shares	Sole	2025-08-14
2025-03-31	$10,059,918	1,441,249	0.0%	Shares	Sole	2025-08-06
2024-12-31	$21,114,297	1,441,249	-5.0%	Shares	Sole	2025-02-14
2024-09-30	$29,029,025	1,516,668	-3.2%	Shares	Sole	2024-11-14
2024-06-30	$27,589,023	1,566,668	—	Shares	Sole	2024-08-16
No filing history on record for this holder in this stock.